<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Analysis &#8211; MicrobiomePost</title>
	<atom:link href="https://microbiomepost.com/company-business-functions/analysis/feed/" rel="self" type="application/rss+xml" />
	<link>https://microbiomepost.com</link>
	<description></description>
	<lastBuildDate>Mon, 04 Aug 2025 14:22:10 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.7.5</generator>

<image>
	<url>https://microbiomepost.com/wp-content/uploads/2025/03/cropped-Favicon_MBP-1-32x32.png</url>
	<title>Analysis &#8211; MicrobiomePost</title>
	<link>https://microbiomepost.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Synaptiflora</title>
		<link>https://microbiomepost.com/microbiome-companies/synaptiflora/</link>
		
		<dc:creator><![CDATA[Fedor Lipskerov]]></dc:creator>
		<pubDate>Sat, 02 Aug 2025 09:22:16 +0000</pubDate>
				<guid isPermaLink="false">https://microbiomepost.com/?post_type=microbiome-companies&#038;p=27208</guid>

					<description><![CDATA[Synaptiflora is an AI-powered SaaS platform that integrates microbiome, genomic, and clinical data to predict drug response, improve patient stratification, and accelerate clinical trials. Backed by a proprietary database and validated by pharma leaders, our technology reduces trial costs, identifies novel biomarkers, and enables precision drug development across oncology, immunology, and beyond.]]></description>
										<content:encoded><![CDATA[<p>Synaptiflora is an AI-powered SaaS platform that integrates microbiome, genomic, and clinical data to predict drug response, improve patient stratification, and accelerate clinical trials. Backed by a proprietary database and validated by pharma leaders, our technology reduces trial costs, identifies novel biomarkers, and enables precision drug development across oncology, immunology, and beyond.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>CD Formulation</title>
		<link>https://microbiomepost.com/microbiome-companies/cd-formulation/</link>
		
		<dc:creator><![CDATA[Staff]]></dc:creator>
		<pubDate>Tue, 05 Dec 2023 08:05:07 +0000</pubDate>
				<guid isPermaLink="false">https://microbiome-hub.com/?post_type=microbiome-companies&#038;p=22576</guid>

					<description><![CDATA[CD Formulation performs a series of microbial tests : Aerobic colony count Yeast and mold count Enrichment method for specific pathogen screening Total gram negative test]]></description>
										<content:encoded><![CDATA[<p>CD Formulation performs a series of microbial tests :</p>
<p>Aerobic colony count<br />
Yeast and mold count<br />
Enrichment method for specific pathogen screening<br />
Total gram negative test</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Alfa Chemistry</title>
		<link>https://microbiomepost.com/microbiome-companies/alfa-chemistry/</link>
		
		<dc:creator><![CDATA[Staff]]></dc:creator>
		<pubDate>Tue, 05 Dec 2023 07:54:26 +0000</pubDate>
				<guid isPermaLink="false">https://microbiome-hub.com/?post_type=microbiome-companies&#038;p=22573</guid>

					<description><![CDATA[Alfa Chemistry’s in-depth translational medicine platform provides pharmaceutical companies and research institutions with a full range of integrated pharmaceutical services. Our non-clinical R&#38;D services cover the full spectrum of preclinical new drug research in pharmaceuticals, including drug discovery, pharmacology studies, and preclinical studies.]]></description>
										<content:encoded><![CDATA[<p>Alfa Chemistry’s in-depth translational medicine platform provides pharmaceutical companies and research institutions with a full range of integrated pharmaceutical services. Our non-clinical R&amp;D services cover the full spectrum of preclinical new drug research in pharmaceuticals, including drug discovery, pharmacology studies, and preclinical studies.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Creative BioMart Microbe</title>
		<link>https://microbiomepost.com/microbiome-companies/creative-biomart-microbe/</link>
		
		<dc:creator><![CDATA[Staff]]></dc:creator>
		<pubDate>Thu, 09 Nov 2023 07:26:47 +0000</pubDate>
				<guid isPermaLink="false">https://microbiome-hub.com/?post_type=microbiome-companies&#038;p=22447</guid>

					<description><![CDATA[Creative BioMart Microbe provides microbiological services and products to multi-industry customers. Our professional technical team experts have the potential to unleash our energy and provide our customers with quality products and services.]]></description>
										<content:encoded><![CDATA[<p>Creative BioMart Microbe provides microbiological services and products to multi-industry customers. Our professional technical team experts have the potential to unleash our energy and provide our customers with quality products and services.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>PHYLOGENE</title>
		<link>https://microbiomepost.com/microbiome-companies/phylogene/</link>
		
		<dc:creator><![CDATA[gilbert skorski]]></dc:creator>
		<pubDate>Fri, 22 Sep 2023 08:04:19 +0000</pubDate>
				<guid isPermaLink="false">https://microbiome-hub.com/?post_type=microbiome-companies&#038;p=22129</guid>

					<description><![CDATA[Phylogene is an R&#38;D and testing company involved in proteomics, metaproteomics, metabolomics, genomics, metagenomics and dedicated bioinformatics. samples such as skin, biopsies, stools,cells; expertise is on drug or active component effect determination activities, biomarker discovery, quantification and validation, up to perfecting of analytical techniques and diagnostics. Involved technologies are immunochemistry, mass spectrometry, PCR, rtPCR, sequencing [&#8230;]]]></description>
										<content:encoded><![CDATA[<p> Phylogene is an R&amp;D and testing company involved in proteomics, metaproteomics, metabolomics, genomics, metagenomics and dedicated bioinformatics. samples such as skin, biopsies, stools,cells; expertise is on drug or active component effect determination activities, biomarker discovery, quantification and validation, up to perfecting of analytical techniques and diagnostics. Involved technologies are immunochemistry, mass spectrometry, PCR, rtPCR, sequencing and dedicated bioinformatics. </p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>vermicon AG</title>
		<link>https://microbiomepost.com/microbiome-companies/vermicon-ag/</link>
		
		<dc:creator><![CDATA[Staff]]></dc:creator>
		<pubDate>Mon, 11 Sep 2023 11:41:28 +0000</pubDate>
				<guid isPermaLink="false">https://microbiome-hub.com/?post_type=microbiome-companies&#038;p=21976</guid>

					<description><![CDATA[With more than 25 years of expertise in the field of microbiological biocenosis and cultivation-independent methods, vermicon AG succeeds in the rapid enumeration, identification, and visualization of microorganisms directly in the probiotic sample. Providing&#160;customized microbiological solutions for all stages of the development and manufacturing pipeline, vermicon AG&#160;is a reliable partner for pharmaceutical producers of microbiological [&#8230;]]]></description>
										<content:encoded><![CDATA[
<p>With more than 25 years of expertise in the field of microbiological biocenosis and cultivation-independent methods, vermicon AG succeeds in the rapid enumeration, identification, and visualization of microorganisms directly in the probiotic sample. Providing&nbsp;customized microbiological solutions for all stages of the development and manufacturing pipeline, vermicon AG&nbsp;is a reliable partner for pharmaceutical producers of microbiological drugs and dietary supplements, CDMOs and other companies and institutes active in the field of microbiome research.<strong></strong></p>



<p>One of the company’s core technologies is VIT® (vermicon identification technology), the further development and industry standardization of fluorescence in situ hybridization (FISH). The analysis is performed by fluorescence microscopy or flow cytometry (Flow VIT®). VIT® and Flow VIT® can specifically identify multiple bacterial populations and species in the same sample, distinguish between live and dead cells, and are cultivation-independent technologies.&nbsp;</p>



<p>The combination of molecular methods with flow cytometry, which is achieved with the Flow VIT® technology, ensures rapid and accurate identification and enumeration of specific bacterial species. As a result, this technology is crucial for the quality control and efficacy of science-based next-generation probiotics.</p>



<h2 class="wp-block-heading" id="h-why-choose-vermicon">Why choose vermicon?</h2>



<ul class="wp-block-list">
<li>Rapid&nbsp;<strong>enumeration</strong>&nbsp;of multiple bacterial species in the same sample</li>



<li><strong>Spatial analysis, identification</strong>&nbsp;and&nbsp;<strong>visualization</strong></li>



<li><strong>Viability, activity&nbsp;</strong>and&nbsp;<strong>safety</strong>&nbsp;analysis</li>



<li>Validation of&nbsp;<strong>stability</strong>&nbsp;and&nbsp;<strong>viability throughout shelf life</strong></li>



<li><strong>End products composition</strong>&nbsp;validation</li>



<li>Microbial&nbsp;<strong>quality</strong>&nbsp;monitoring</li>



<li><strong>Contaminants control</strong></li>
</ul>



<h2 class="wp-block-heading">How to implement?&nbsp;</h2>



<p>Using the VIT® and Flow VIT® technologies, vermicon AG performs a wide range of&nbsp;<strong>laboratory analyses</strong>&nbsp;under both GMP and non-GMP conditions. Additionally, the detection systems include&nbsp;<strong>standard</strong>&nbsp;and&nbsp;<strong>customized test kits</strong>&nbsp;and enable an easy-to-use in-house analysis of microorganisms.</p>



<p>Additionally, with over 25 years of experience in analyzing complex microbiological ecosystems, vermicon AG offers expert&nbsp;<strong>consulting services</strong>&nbsp;to help solve even the most challenging microbiological questions.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>CosmosID, Inc.</title>
		<link>https://microbiomepost.com/microbiome-companies/cosmosid-inc/</link>
		
		<dc:creator><![CDATA[Staff]]></dc:creator>
		<pubDate>Fri, 10 Mar 2023 14:22:25 +0000</pubDate>
				<guid isPermaLink="false">https://microbiomehub.videe.co/?post_type=microbiome-companies&#038;p=20152</guid>

					<description><![CDATA[CosmosID is a leading provider of end-to-end microbiome analysis solutions.]]></description>
										<content:encoded><![CDATA[
<p>CosmosID® provides end-to-end solutions unlocking the microbiome. A provider of CLIA-certified &amp; GxP-compliant NGS, metabolomics and bioinformatics aolutions, CosmosID offers a range of validated and optimized workflows for early and late stage R&amp;D.</p>



<p>CosmosID also offers independently validated, industry-leading pipelines for processing metagenomic data, yielding multi-kingdom, strain-level resolution with leading sensitivity and precision. Results can be accessed via CosmosID-HUB, a user-friendly and interactive software for comparative analysis of microbiome data, complete with dynamic charts, visualizations, and statistics.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Wellmicro Srl</title>
		<link>https://microbiomepost.com/microbiome-companies/wellmicro-srl/</link>
		
		<dc:creator><![CDATA[Staff]]></dc:creator>
		<pubDate>Fri, 21 Oct 2022 13:38:23 +0000</pubDate>
				<guid isPermaLink="false">https://microbiomehub.videe.co/?post_type=microbiome-companies&#038;p=18149</guid>

					<description><![CDATA[Wellmicro® for your wellbeing.]]></description>
										<content:encoded><![CDATA[
<p>Italian leader in microbiota research, thanks to its scientific know-how, Wellmicro® is the only Italian <strong>Microbiota Based Company</strong> developed on patented and scientifically validated methods.<br>Our mission is to make <strong>scientific evidences</strong>, born in laboratory and <strong>confirmed by data</strong>, an advantage for individuals’ health.</p>



<p>Wellmicro® Academy claims a solid support to the clinical board of professionals alongside with the scientific board.</p>



<h2 class="wp-block-heading" id="h-locations">Locations</h2>



<ul class="wp-block-list">
<li>Legal head office: 1&nbsp;Bruno Rizzi St. Bussolengo &#8211; Verona 37012 IT</li>
</ul>



<ul class="wp-block-list">
<li>Headquarter: 30&nbsp;Antonio Canova St. Bologna 40138 IT</li>
</ul>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>MICRO</title>
		<link>https://microbiomepost.com/microbiome-companies/micro-srl/</link>
		
		<dc:creator><![CDATA[Staff]]></dc:creator>
		<pubDate>Wed, 28 Sep 2022 09:16:59 +0000</pubDate>
				<guid isPermaLink="false">https://microbiomehub.videe.co/?post_type=microbiome-companies&#038;p=17600</guid>

					<description><![CDATA[Microbiological analysis and beyond analysis.]]></description>
										<content:encoded><![CDATA[<p>MICRO was established in July 2003 by Dr. Franco Pirovano and performs microbiological analysis in various sectors, such as nutraceuticals, supplements, cosmetics and pet food.<br />
It is accredited by ACCREDIA, which certifies that the laboratory complies with the UNI CEI EN ISO/IEC 17025 standard.<br />
The MICRO team not only performs analyses but is also proactive towards customers.<br />
MICRO: the fil rouge that links people, work, and research.<br />
MICRO is #plasticfree: a small gesture for a big problem.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Bio-Me</title>
		<link>https://microbiomepost.com/microbiome-companies/bio-me/</link>
		
		<dc:creator><![CDATA[Staff]]></dc:creator>
		<pubDate>Wed, 07 Sep 2022 09:00:49 +0000</pubDate>
				<guid isPermaLink="false">https://microbiomehub.videe.co/?post_type=microbiome-companies&#038;p=17391</guid>

					<description><![CDATA[Our qPCR-based platform enables rapid, targeted, and cost-effective microbiome profiling (PMP™).]]></description>
										<content:encoded><![CDATA[
<p>The mission of Bio-Me is to provide researchers and industry with a microbiome analysis platform that delivers actionable microbiome results in a reliable and quick way.</p>



<p>Next-generation sequencing (NGS) technologies have been crucial in investigating and characterizing the human microbiome. However, the transformation of NGS data into actionable solutions is limited by challenges related to precision, turnaround time, cost per sample, and the need for complex bioinformatic pipelines. For this purpose, Bio-Me developed Precision Microbiome Profiling (PMP™) in collaboration with Thermo Fisher Scientific. PMP™ is a novel qPCR-based platform that allows accurate, quick (100-200 samples in 2 hours), reproducible, and cost-efficient large-scale microbiome profiling at the species/strain level. The output consists of quantitative and ready-to-use results, overcoming the need for bioinformatics data processing.</p>



<p>Bio-Me’s proprietary pipeline allows the development of specific qPCR assays for the microbial targets of interest. We currently offer four off-the-shelf profiling solutions:</p>



<ol class="wp-block-list">
<li>Gut Microbiome Extensive Panel</li>



<li>IBD/IBS/Gut Health Screening Microbiome Panel</li>



<li>Colorectal Cancer Microbiome Panel</li>



<li>Vaginal Microbiome Panel</li>
</ol>



<p>In addition, we offer a convenient gut microbiome sampling solution as a kit and extraction/purification of DNA.</p>



<p>Moreover, we are developing a dedicated skin microbiome panel covering major organisms important for skin health. We are also working on an immuno-oncology and an infant gut health panel. Thanks to the flexibility of the PMP™ platform, we can customize microbiome profiling panels according to our clients’ needs.</p>



<p>Bio-Me works with leading academic institutions worldwide and key opinion leaders in the microbiome field. We support pharma and biotech companies during the clinical development of microbiome-modifying drugs with our profiling solutions and our access to fecal samples and anonymized medical registries from more than 13 000 subjects (collaboration with HUNT4). In addition, Bio-Me participates in clinical trials for several disease areas, such as cancer immunotherapy, IBD, and colorectal cancer.</p>



<h2 class="wp-block-heading" id="h-key-features-of-pmp">Key Features of PMP™</h2>



<ul class="wp-block-list">
<li>End-to-end solution – From sample collection kit to microbiome profile results</li>



<li>Short turnaround time – Results ready in 2-5 hours from sample arrival</li>



<li>High throughput – Hundreds of samples analyzed simultaneously</li>



<li>Ready-to-use results – No bioinformatics steps needed from your side for data processing</li>



<li>Absolute quantification – The output is the number of genomes per ng of DNA</li>



<li>High-level resolution – Species, subspecies, and strain level</li>



<li>Highly reproducible and accurate</li>
</ul>



<h2 class="wp-block-heading">Products and offerings</h2>



<div style="height:24px" aria-hidden="true" class="wp-block-spacer"></div>



<h3 class="wp-block-heading has-text-align-left">Off-the-Shelf Offerings</h3>



<figure class="wp-block-table is-style-stripes"><table class="has-fixed-layout"><thead><tr><th class="has-text-align-left" data-align="left"><strong>Products and services</strong></th><th class="has-text-align-left" data-align="left"><strong>Description</strong></th></tr></thead><tbody><tr><td class="has-text-align-left" data-align="left">Gut Microbiome Extensive Panel v1.2</td><td class="has-text-align-left" data-align="left">~ 100 target organisms, species/subspecies level</td></tr><tr><td class="has-text-align-left" data-align="left">IBD/IBS/Gut Health ScreeningMicrobiome Panel v1.2</td><td class="has-text-align-left" data-align="left">~ 100 target organisms, species/subspecies level</td></tr><tr><td class="has-text-align-left" data-align="left">Colorectal Cancer Microbiome Panel v1.0</td><td class="has-text-align-left" data-align="left">~ 50 target organisms, species/subspecies level</td></tr><tr><td class="has-text-align-left" data-align="left">Vaginal Microbiome Panel v1.0</td><td class="has-text-align-left" data-align="left">34 bacterial, viral, and fungal targets</td></tr><tr><td class="has-text-align-left" data-align="left">Fecal Collection Kit</td><td class="has-text-align-left" data-align="left">For sampling and storing of fecal material</td></tr><tr><td class="has-text-align-left" data-align="left">DNA extraction/purification</td><td class="has-text-align-left" data-align="left">From fecal samples</td></tr></tbody></table></figure>



<div style="height:24px" aria-hidden="true" class="wp-block-spacer"></div>



<h3 class="wp-block-heading has-text-align-left">Custom Solutions</h3>



<figure class="wp-block-table is-style-stripes"><table class="has-fixed-layout"><thead><tr><th class="has-text-align-left" data-align="left"><strong>Products and services</strong></th><th class="has-text-align-left" data-align="left">Description</th></tr></thead><tbody><tr><td class="has-text-align-left" data-align="left">PMP™&nbsp;Custom 56</td><td class="has-text-align-left" data-align="left">56 target organisms from library of ~ 180 assays</td></tr><tr><td class="has-text-align-left" data-align="left">PMP™&nbsp;Assay Development</td><td class="has-text-align-left" data-align="left">Design of new specific qPCR assays</td></tr></tbody></table></figure>



<div style="height:24px" aria-hidden="true" class="wp-block-spacer"></div>



<h3 class="wp-block-heading has-text-align-left">Under Development</h3>



<figure class="wp-block-table is-style-stripes"><table class="has-fixed-layout"><thead><tr><th class="has-text-align-left" data-align="left"><strong>Products and services</strong></th><th class="has-text-align-left" data-align="left"><strong>Description</strong></th></tr></thead><tbody><tr><td class="has-text-align-left" data-align="left">Skin microbiome panel&nbsp;</td><td class="has-text-align-left" data-align="left">~ 15 target organisms</td></tr><tr><td class="has-text-align-left" data-align="left">Immuno-oncology panel&nbsp;</td><td class="has-text-align-left" data-align="left">~ 50 target organisms</td></tr><tr><td class="has-text-align-left" data-align="left">Infant gut health panel</td><td class="has-text-align-left" data-align="left">~ 50 target organisms</td></tr></tbody></table></figure>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
